Morphine

Morphine

SCHEMBL2421178

CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Morphine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 known ✓ P35372 8/20 1.00
▸ OPRD1 P41143 11/20 1.00
▸ OPRK1 P41145 7/20 1.00
▸ MRGPRX2 Q96LB1 4/20 1.00
▸ SLC22A1 O15245 1/20 1.00
▸ ADRA2A P08913 1/20 1.00
▸ ARRB1 P49407 1/20 1.00
▸ ADRB1 P08588 1/20 0.76
▸ PDE4D Q08499 1/20 0.76
▸ PDE3A Q14432 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morphine SCHEMBL10031250 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL8285398 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL15501048 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL4545441 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL6393384 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL12125412 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL24599520 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL12717556 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL5674635 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL13695381 1.00 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1236758-C Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle WANG YUWAN (CN) 2006-01-18 — — CN claimed
CN-1461639-A Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle WANG YUWAN (CN) 2003-12-17 — — CN claimed
US-20240194304-A1 Prediction Method, Prediction Device, and Prediction Program for New Indication of Desired Known Drug or Equivalent Material Thereof KARYDO THERAPEUTIX, INC. (JP) 2024-06-13 — — US disclosed
EP-3675838-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS Puretecch LYT, Inc. (US) 2020-07-08 — — EP disclosed
EP-3631000-A1 RAPID SAMPLE TEMPERATURE CHANGING FOR ASSAYING Essenlix Corporation (US) 2020-04-08 — — EP disclosed
CN-110452217-A Optical voidness haptens for nicotine vaccine development SCRIPPS RES INSTITUTE 2019-11-15 — — CN disclosed
WO-2019046491-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS ARIYA THERAPEUTICS, INC. (US) 2019-03-07 — — WO disclosed
WO-2018217953-A1 RAPID SAMPLE TEMPERATURE CHANGING FOR ASSAYING ESSENLIX CORPORATION (US) 2018-11-29 — — WO disclosed
WO-2018148342-A1 COMPRESSED OPEN FLOW ASSAY AND USE ESSENLIX CORPORATION (US) 2018-08-16 — — WO disclosed
EP-3137065-A2 COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES Pharnext (FR) 2017-03-08 — — EP disclosed
WO-2015165948-A2 COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES PHARNEXT (FR) 2015-11-05 — — WO disclosed
CN-1187618-C Reagent box for fast detecting methyl amphetamine and its preparation process KAICHUANG BIOTECHNOLOGY CO LTD (CN) 2005-02-02 — — CN disclosed
CN-1461639-A Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle WANG YUWAN (CN) 2003-12-17 — — CN disclosed
CN-1410770-A Reagent box for fast detecting methyl amphetamine and its preparation process KAICHUANG BIOTECHNOLOGY CO LTD (CN) 2003-04-16 — — CN disclosed
US-5952235-A SOLVENT EXTRACTING MECONIUM SAMPLE, APPLYING TO NON-AMINE COLUMN, ELUTING AND DETECTING FATTY ACID ESTER; FOR ACURATE DIAGNOSIS OF FETAL ALCHOHOL SYNDROME CASE WESTERN RESERVE UNIVERSITY (US) 1999-09-14 — — US disclosed
US-5633259-A ETORPHINE-TYPE ANALGESIC UNITED BIOMEDICAL, INC. (US) 1997-05-27 — — US disclosed
US-5624932-A ETORPHINE UNITED BIOMEDICAL, INC. (US) 1997-04-29 — — US disclosed
EP-0668764-A1 METHODS FOR IDENTIFYING AND USING LOW/NON-ADDICTIVE OPIOID ANALGESICS QIN, Bo-yi (CN) 1995-08-30 — — EP disclosed
WO-1994006426-A1 METHODS FOR IDENTIFYING AND USING LOW/NON-ADDICTIVE OPIOID ANALGESICS QIN BO YI (CN) 1994-03-31 — — WO disclosed
US-5116873-A Thyroid Hormone T4 GORIO ALFREDO (IT) 1992-05-26 — — US disclosed
Send feedback